Body composition changes across a spectrum of hypothyroidism severity - a systematic review and meta-analysis.

IF 8 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Derrick Kretli-Souza, Nathalia Elizabete Paulino, Raiane Aparecida Asevedo, Sara Cristina Leonel Lemos, Gabriel Meireles-Oliveira, Yuri Alves-Silva, Ingrid Rodrigues Hortêncio-Medeiros, Candido Celso Coimbra, Rodrigo Antonio Peliciari-Garcia, Lucas Rios Drummond, Helton Oliveira Campos, Paula Bargi-Souza
{"title":"Body composition changes across a spectrum of hypothyroidism severity - a systematic review and meta-analysis.","authors":"Derrick Kretli-Souza, Nathalia Elizabete Paulino, Raiane Aparecida Asevedo, Sara Cristina Leonel Lemos, Gabriel Meireles-Oliveira, Yuri Alves-Silva, Ingrid Rodrigues Hortêncio-Medeiros, Candido Celso Coimbra, Rodrigo Antonio Peliciari-Garcia, Lucas Rios Drummond, Helton Oliveira Campos, Paula Bargi-Souza","doi":"10.1007/s11154-025-09988-z","DOIUrl":null,"url":null,"abstract":"<p><p>This systematic review and meta-analysis aimed to investigate the impact of clinical hypothyroidism (CH) and subclinical hypothyroidism (SCH) on anthropometric parameters, such as body mass index (BMI), body weight (BW), waist circumference (WC), Hip Circumference (HC), Waist Circumference (WC) and Waist-Hip ratio (W/H). Databases including PubMed, Web of Science, Scopus, and EMBASE were searched for observational studies on hypothyroidism and body composition. The review included 38 studies (54 comparison groups, 49,427 individuals). Effect sizes (ES) with 95% confidence intervals (CI) were used to measure the effects of CH and SCH on body composition compared to healthy controls and between themselves. Effect sizes were defined as negligible (< 0.2), small (0.20-0.49), moderate (0.50-0.79), and large (> 0.8). CH showed large increases in BMI (ES = 1.092; CI: 0.755, 1.429) and BW (ES = 0.897; CI: 0.404, 1.389), and moderate increases in WC (ES = 0.759; CI: 0.419, 1.099) and fat mass (ES = 0.609; CI: 0.051, 1.167). SCH showed moderate increases in BMI (ES = 0.596; CI: 0.403, 0.789) and BW (ES = 0.712; CI: 0.287, 1.138), a small increase in WC (ES = 0.298; CI: 0.141, 0.454), with negligible fat mass changes (ES=-0.055; CI: - 0.760, 0.649). Analysis of SCH by thyroid-stimulating hormone (TSH) levels revealed greater impacts on body composition with increasing TSH. In turn, BMI (ES=-0.082; CI: - 0.577, 0.413) and BW (ES = 0.054; CI: - 0.441, 0.550) showed no significant changes at near-normal TSH (4.0-4.9 mIU/L). Moderate TSH elevation (5.0-10.0 mIU/L) led to moderate increases in BMI (ES = 0.584; CI: 0.343, 0.825) and BW (ES = 0.659; CI: 0.245, 1.073), with a small WC increase (ES = 0.271; CI: 0.077,0.465). TSH > 10.0 mIU/L resulted in large increases in BMI (ES = 1.426; CI: 0.614, 2.238) and BW (ES = 1.942; CI: 1.550, 2.334), along with a small WC increase (ES = 0.271; CI: 0.077, 0.465). The comparison regarding BMI, WC and BW showed no differences between CH and SCH. Both CH and SCH are associated with changes in body composition, mainly BMI, WC, and BW, which may contribute to metabolic risk. Body composition worsens in SCH as TSH levels rise, and stronger effects are evidenced in females and symptomatic individuals.</p>","PeriodicalId":21106,"journal":{"name":"Reviews in Endocrine & Metabolic Disorders","volume":" ","pages":""},"PeriodicalIF":8.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in Endocrine & Metabolic Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11154-025-09988-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

This systematic review and meta-analysis aimed to investigate the impact of clinical hypothyroidism (CH) and subclinical hypothyroidism (SCH) on anthropometric parameters, such as body mass index (BMI), body weight (BW), waist circumference (WC), Hip Circumference (HC), Waist Circumference (WC) and Waist-Hip ratio (W/H). Databases including PubMed, Web of Science, Scopus, and EMBASE were searched for observational studies on hypothyroidism and body composition. The review included 38 studies (54 comparison groups, 49,427 individuals). Effect sizes (ES) with 95% confidence intervals (CI) were used to measure the effects of CH and SCH on body composition compared to healthy controls and between themselves. Effect sizes were defined as negligible (< 0.2), small (0.20-0.49), moderate (0.50-0.79), and large (> 0.8). CH showed large increases in BMI (ES = 1.092; CI: 0.755, 1.429) and BW (ES = 0.897; CI: 0.404, 1.389), and moderate increases in WC (ES = 0.759; CI: 0.419, 1.099) and fat mass (ES = 0.609; CI: 0.051, 1.167). SCH showed moderate increases in BMI (ES = 0.596; CI: 0.403, 0.789) and BW (ES = 0.712; CI: 0.287, 1.138), a small increase in WC (ES = 0.298; CI: 0.141, 0.454), with negligible fat mass changes (ES=-0.055; CI: - 0.760, 0.649). Analysis of SCH by thyroid-stimulating hormone (TSH) levels revealed greater impacts on body composition with increasing TSH. In turn, BMI (ES=-0.082; CI: - 0.577, 0.413) and BW (ES = 0.054; CI: - 0.441, 0.550) showed no significant changes at near-normal TSH (4.0-4.9 mIU/L). Moderate TSH elevation (5.0-10.0 mIU/L) led to moderate increases in BMI (ES = 0.584; CI: 0.343, 0.825) and BW (ES = 0.659; CI: 0.245, 1.073), with a small WC increase (ES = 0.271; CI: 0.077,0.465). TSH > 10.0 mIU/L resulted in large increases in BMI (ES = 1.426; CI: 0.614, 2.238) and BW (ES = 1.942; CI: 1.550, 2.334), along with a small WC increase (ES = 0.271; CI: 0.077, 0.465). The comparison regarding BMI, WC and BW showed no differences between CH and SCH. Both CH and SCH are associated with changes in body composition, mainly BMI, WC, and BW, which may contribute to metabolic risk. Body composition worsens in SCH as TSH levels rise, and stronger effects are evidenced in females and symptomatic individuals.

甲状腺功能减退严重程度的身体成分变化——一项系统回顾和荟萃分析。
本研究旨在探讨临床甲状腺功能减退症(CH)和亚临床甲状腺功能减退症(SCH)对身体质量指数(BMI)、体重(BW)、腰围(WC)、臀围(HC)、腰围(WC)和腰臀比(W/H)等人体测量参数的影响。检索了PubMed、Web of Science、Scopus和EMBASE等数据库,查找甲状腺功能减退和身体成分的观察性研究。该综述包括38项研究(54个对照组,49,427人)。采用95%置信区间(CI)的效应量(ES)来测量与健康对照相比,CH和SCH对身体成分的影响,以及它们之间的影响。效应量被定义为可忽略(0.8)。CH组BMI显著升高(ES = 1.092;CI: 0.755, 1.429)和体重(ES = 0.897;CI: 0.404, 1.389), WC有中度升高(ES = 0.759;CI: 0.419, 1.099)和脂肪量(ES = 0.609;Ci: 0.051, 1.167)。SCH组BMI有中度升高(ES = 0.596;CI: 0.403, 0.789)和体重(ES = 0.712;CI: 0.287, 1.138), WC略有增加(ES = 0.298;CI: 0.141, 0.454),脂肪量变化可以忽略不计(ES=-0.055;Ci: - 0.760, 0.649)。通过促甲状腺激素(TSH)水平对SCH的分析显示,随着TSH的增加,对身体成分的影响更大。BMI (ES=-0.082;CI: - 0.577, 0.413)和体重(ES = 0.054;CI: - 0.441, 0.550)显示接近正常TSH (4.0-4.9 mIU/L)无显著变化。中度TSH升高(5.0 ~ 10.0 mIU/L)导致BMI中度升高(ES = 0.584;CI: 0.343, 0.825)和体重(ES = 0.659;CI: 0.245, 1.073), WC略有增加(ES = 0.271;置信区间:0.077,0.465)。10.0 mIU/L TSH >导致BMI大幅增加(ES = 1.426;CI: 0.614, 2.238)和体重(ES = 1.942;CI: 1.550, 2.334),同时WC略有增加(ES = 0.271;Ci: 0.077, 0.465)。BMI、WC和BW的比较显示,CH和SCH之间没有差异。CH和SCH都与身体组成的变化有关,主要是BMI、WC和BW的变化,这些变化可能与代谢风险有关。随着TSH水平的升高,SCH患者的身体成分会恶化,在女性和有症状的个体中表现出更强的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reviews in Endocrine & Metabolic Disorders
Reviews in Endocrine & Metabolic Disorders 医学-内分泌学与代谢
CiteScore
14.70
自引率
1.20%
发文量
75
审稿时长
>12 weeks
期刊介绍: Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to the field of endocrinology and metabolism. It aims to provide the latest advancements in this rapidly advancing field to students, clinicians, and researchers. Unlike other journals, each quarterly issue of this review journal focuses on a specific topic and features ten to twelve articles written by world leaders in the field. These articles provide brief overviews of the latest developments, offering insights into both the basic aspects of the disease and its clinical implications. This format allows individuals in all areas of the field, including students, academic clinicians, and practicing clinicians, to understand the disease process and apply their knowledge to their specific areas of interest. The journal also includes selected readings and other essential references to encourage further in-depth exploration of specific topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信